(NASDAQ: ANNX) Annexon's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 48.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 43.3%.
Annexon's earnings in 2025 is -$208,881,000.On average, 10 Wall Street analysts forecast ANNX's earnings for 2025 to be -$167,461,999, with the lowest ANNX earnings forecast at -$167,653,412, and the highest ANNX earnings forecast at -$163,298,777. On average, 10 Wall Street analysts forecast ANNX's earnings for 2026 to be -$160,032,802, with the lowest ANNX earnings forecast at -$186,411,835, and the highest ANNX earnings forecast at -$91,698,544.
In 2027, ANNX is forecast to generate -$100,551,372 in earnings, with the lowest earnings forecast at -$134,826,170 and the highest earnings forecast at -$67,831,800.